Papilloma
10
0
1
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
20.0%
2 terminated out of 10 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
Intended Use Study of the BD SurePath Plus™ Pap
Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions
New Therapy of Laryngeal Papilloma In Children
Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract
The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
Squamous Cell Carcinoma Antigen Analysis at the University Hospital Ostrava
Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)
The Effects of Upper Airway and Digestive Tract Tumors on the Immune System
A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis